David Wilson is Senior Counsel in the Intellectual Property and Technology practice. He advises clients on patent litigation, technology licensing, and IP-driven M&A across the pharmaceutical, biotechnology, software, and semiconductor industries.
David has an extensive track record in high-value patent disputes before the UK Intellectual Property Enterprise Court, the Patents Court, and the European Patent Office. He has also advised on IP due diligence and licensing strategy for a number of landmark technology transactions.
David is recognized by The Legal 500 as a "Recommended Lawyer" in Patent Litigation and is a Fellow of the Chartered Institute of Patent Attorneys.
Experience
Experience
—
Led a multi-jurisdictional patent dispute for a global pharmaceutical company involving patents covering a blockbuster oncology drug
—
Advised a US semiconductor firm on the IP structuring and licensing terms for a £2 billion technology acquisition
—
Counsel to a UK biotechnology company in EPO opposition proceedings and parallel High Court revocation actions
—
Negotiated a complex cross-licensing agreement between two competing technology platforms valued at over £500 million
Insights
Insights
October 24, 2025|Client Update
SEC Draft Registration Statement Accommodations
October 15, 2025|Client Update
SEC Review of Foreign Private Issuer Status
Education
- LL.M.London School of EconomicsDistinction
Prior experience
- Solicitor, IP Department, a Magic Circle firm, 2007–2012
- Technical Advisor, European Patent Office, secondment 2015
Qualifications and admissions
- England and Wales
Languages
- English
- French
Recognition
—
Legal 500 UK – Patent Litigation, Recommended Lawyer
Legal 500 UK – Patent Litigation, Recommended Lawyer
—
IAM Patent 1000 – United Kingdom, Recommended Individual
IAM Patent 1000 – United Kingdom, Recommended Individual
—
Fellow, Chartered Institute of Patent Attorneys
Fellow, Chartered Institute of Patent Attorneys
—
Who's Who Legal – Patents, 2020–2025
Who's Who Legal – Patents, 2020–2025